OncoInsightInsightful Breakthrough Medicine for Immune Cell Therapy
Allogeneic Natural Killer Cells Engineered to Solid tumor
Natural killer cells can be xenografted and have the potential to become off-the-shelf products, making CAR-NK cell therapies universal products. These products are safer than CAR-T cell therapy.
Allogeneic CAR HSC-Derived NK Cellsfor Autoimmune Disease Treatment
CAR HSC-derived NK cells enable breakthrough therapies for B cell-driven autoimmune diseases, including lupus, by providing targeted immune precision, reducing disease progression, and improving long-term outcomes.
Humanized Mice as Unique Tools for Human-Specific Studies
Humanized mice support the development of multiple cellular components of the human immune system, many of which are functional and used in modeling key portions of human immunity.
OUR VISION
To be the leading company delivering innovative,
accessible cell therapies for cancer patients
OUR MISSION
We strive to discover, develop and deliver novel
off-the-shelf NK cell therapy product candidates
that have a profound impact on cancer patients
LEADERSHIP
Deukchae Na, Ph.D.
CHIEF EXECUTIVE OFFICER
Miyeon Lee, MOT
CHIEF OPERATING OFFICER
SCIENTIFIC ADVISORY BOARD
Junwoo Lee, M.D.
- 01
- 02
SCIENCE
PIPELINE
OPEN INNOVATION
